TML-6

N/A

Report date: 2025/06/23 09:09:47

Base Information

Drug NameTML-6
Drug Alias NameTML-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsApolipoprotein E agonistsSerine/threonine-protein kinase mTOR inhibitors +[4] 
TargetsSerine/threonine-protein kinase mTORNuclear factor NF-kappa-B complexApolipoprotein E +[4] 
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorldTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerry Life Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMerry Life Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A